| Limb volume, median |
9.23 (2.46 to 14.69) |
3.3 (2.46 to 4.15) |
10.71 (9.5 to 14.69) |
0.0007 |
| Melphalan dose, median, mg |
50.86 (13.6 to 80.82) |
18.1 (13.6 to 22.6) |
59.04 (44.6 to 80.82) |
0.0046 |
| Actinomycin D dose, median, µg |
450.2 (195 to 500) |
251 (195 to 307) |
500 |
<0.0001 |
| Perfusate blood gas, 30 min ischemia time |
|
|
|
|
| pH, median |
7.204 (7.106 to 7.261) |
7.239 (7.217 to 7.261) |
7.196 (7.106 to 7.255) |
0.3294 |
| Base excess, median |
−10.11 (−6.2 to 15.50) |
−9.05 (−8.1 to 10.0) |
−10.38 (−6.2 to 15.50) |
0.5180 |
| PaO2, median, mm Hg |
20.59 (11.5 to 31.2) |
17.4 (16.8 to 18) |
21.38 (11.5 to 31.2) |
0.4657 |
| Lactate mmol/l |
3.51 (2.04 to 8.29) |
2.3 (2.04 to 2.56) |
3.81 (2.1 to 8.29) |
0.3331 |
| Soft tissue sarcoma subtype, n
|
|
|
|
|
| Angiosarcoma of soft tissue |
1 |
|
|
|
| Dedifferentiated liposarcoma |
1 |
|
|
|
| Desmoid fibromatosis |
2 |
|
|
|
| Malignant fibrous histiocytoma |
2 |
|
|
|
| Pleomorphic rhabdomyosarcoma |
3 |
|
|
|
| Pleomorphic sarcoma |
1 |
|
|
|
